Tentamen (uitwerkingen)
APEA Pharm- Women's Health QUESTIONS AND CORRECT DETAILED ANSWERS |ALREADY GRADED A+
- Vak
- Instelling
APEA Pharm- Women's Health QUESTIONS AND CORRECT DETAILED ANSWERS |ALREADY GRADED A+
[Meer zien]Voorbeeld 2 van de 10 pagina's
Voorbeeld 2 van de 10 pagina's
In winkelwagen
Voorbeeld van de inhoud
APEA Pharm- Women's Health1. A 23-year-old woman complains of breakthrough bleeding 1 month after being started on
a combination oral contraceptive (OC). The nurse practitioner should:
2.
3. advise the patient to use additional protection during intercourse, until resolved.
4. change to a progestin-only formulation.
5. advise the patient that breakthrough bleeding in the first 3 months is common.
6. change to a contraceptive patch for better regulation of hormones. - ANS-advise the
patient that breakthrough bleeding in the first 3 months is common.
7. A 23-year-old woman with a desire for pregnancy needs treatment for symptoms related
to polycystic ovarian syndrome (PCOS). The initial choice is:
8. liraglutide (Victoza).
9. metformin (Glucophage).
10. spironolactone (Aldactone).
11. finasteride (Proscar). - ANS-metformin (Glucophage).
12.
13. Spironolactone and finasteride are second-line therapy options.
14. Victoza is not indicated in the treatment of PCOS.
15. A Bartholin's gland abscess caused by Staphylococcal aureus infection is best treated
with:
16. amoxicillin-clavulanate (Augmentin).
17. cephalexin (Keflex).
18. clindamycin (Cleocin).
19. metronidazole (Flagyl). - ANS-clindamycin (Cleocin).
20.
21. Due to high rates of resistance, penicillin and cephalosporins are not recommended.
Metronidazole is not indicated in the treatment of staphylococcal infections.
22. A benefit associated with the use of medroxyprogesterone acetate (Depo-Provera), a
progestin-only contraceptive, is:
23. decreased risk of pelvic inflammatory disease.
24. decreased risk of cardiovascular risk factors.
25. decreased risk of weight gain.
26. decreased risk of osteoporosis. - ANS-decreased risk of pelvic inflammatory disease.
27. A common side effect associated with the use of progestin-only contraceptives is:
28. depression.
29. amenorrhea.
30. hypertension.
31. edema. - ANS-amenorrhea.
32.
33. Changes in normal menstrual cycle
, 34. Other side effects are breast tenderness, headaches, and mood changes.
35. A woman who has had a hysterectomy complains of vaginal dryness, burning, and
itching. A hormonal treatment is:
36. progesterone only.
37. oral combination contraceptives.
38. low-dose oral estrogen.
39. implanted testosterone pellets. - ANS-low-dose oral estrogen.
40. An oral contraceptive known as the "mini-pill" contains:
41. estrogen only.
42. progesterone only.
43. equal parts estrogen and progesterone.
44. a higher dose of progesterone than estrogen. - ANS-progesterone only.
45. Before prescribing oral contraceptives, the nurse practitioner should check for:
46. anemia.
47. human papillomavirus via Pap test.
48. sexually transmitted diseases.
49. pregnancy. - ANS-pregnancy.
50. Combination estrogen and progesterone therapy:
51.
52. does not increase the risk of heart attack or stroke.
53. increases the risk for deep vein thrombosis (DVT) and gallbladder disease.
54. only increases breast cancer risk in the presence of family history.
55. preserves ovarian function in premenopausal women. - ANS-increases the risk for deep
vein thrombosis (DVT) and gallbladder disease.
56. Combined contraceptive patches:
57. are replaced every 14 days.
58. have fewer side effects than oral contraceptives.
59. may not be as effective in women weighing more than 200 pounds.
60. are safer than oral contraceptives in patients with hypertension. - ANS-may not be as
effective in women weighing more than 200 pounds.
61. Combined contraceptives, whether oral, patch or intravaginal, work in the ovulatory
phase by:
62. increasing follicle-stimulating hormone and luteinizing hormone.
63. decreasing follicle-stimulating hormone and increasing luteinizing hormone.
64. suppressing follicle-stimulating hormone and luteinizing hormones.
65. increasing the release of follicle-stimulating hormone and luteinizing hormone. -
ANS-suppressing follicle-stimulating hormone and luteinizing hormones.
66. Combined oral contraceptive use is absolutely contraindicated in patients who:
67. are older than 35 years and smoke a pack of cigarettes/day.
68. develop migraine headaches after starting oral contraceptives.
69. are 6-12 weeks postpartum and breastfeeding.
70. had breast cancer more than 5 years ago. - ANS-are older than 35 years and smoke a
pack of cigarettes/day.
71.
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
√ Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, Bancontact of creditcard voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper Ashley96. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor $12.99. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 67866 samenvattingen verkocht
Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen
